MELIS, GIAN BENEDETTO
 Distribuzione geografica
Continente #
EU - Europa 332.604
NA - Nord America 29.017
AS - Asia 4.196
Continente sconosciuto - Info sul continente non disponibili 53
SA - Sud America 39
AF - Africa 36
OC - Oceania 27
Totale 365.972
Nazione #
IT - Italia 319.818
US - Stati Uniti d'America 28.785
UA - Ucraina 4.541
CN - Cina 3.140
DE - Germania 2.787
SE - Svezia 2.491
FI - Finlandia 1.018
GB - Regno Unito 908
SG - Singapore 715
RU - Federazione Russa 402
FR - Francia 385
CA - Canada 214
IN - India 140
BE - Belgio 55
EU - Europa 53
NL - Olanda 45
KR - Corea 43
VN - Vietnam 38
TR - Turchia 25
CH - Svizzera 23
BR - Brasile 22
ES - Italia 19
RO - Romania 18
AU - Australia 17
JP - Giappone 17
MU - Mauritius 16
CZ - Repubblica Ceca 14
MX - Messico 13
PL - Polonia 13
IE - Irlanda 12
TH - Thailandia 11
IL - Israele 10
NZ - Nuova Zelanda 10
BG - Bulgaria 9
IR - Iran 8
TW - Taiwan 8
ID - Indonesia 7
PT - Portogallo 7
GE - Georgia 6
NO - Norvegia 6
PH - Filippine 6
ZA - Sudafrica 6
AL - Albania 5
CL - Cile 5
GR - Grecia 5
CO - Colombia 4
DK - Danimarca 4
HR - Croazia 4
MY - Malesia 4
DZ - Algeria 3
EC - Ecuador 3
EG - Egitto 3
IS - Islanda 3
ME - Montenegro 3
RS - Serbia 3
AE - Emirati Arabi Uniti 2
BD - Bangladesh 2
HK - Hong Kong 2
JO - Giordania 2
LY - Libia 2
MN - Mongolia 2
NG - Nigeria 2
PA - Panama 2
PE - Perù 2
TN - Tunisia 2
VE - Venezuela 2
AM - Armenia 1
AR - Argentina 1
AT - Austria 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BY - Bielorussia 1
HN - Honduras 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
MG - Madagascar 1
OM - Oman 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
ZW - Zimbabwe 1
Totale 365.972
Città #
Cagliari 310.926
Uta 6.288
Fairfield 3.255
Chandler 2.829
Woodbridge 2.666
Jacksonville 2.451
Boardman 2.179
Ann Arbor 1.950
Houston 1.773
Ashburn 1.747
Wilmington 1.650
Seattle 1.313
Nyköping 1.255
Cambridge 1.060
Dearborn 750
Nanjing 747
Boston 477
Helsinki 348
Beijing 346
Singapore 293
Milan 287
Shenyang 236
Nanchang 214
San Diego 185
Toronto 183
Verona 179
Hebei 166
Guangzhou 163
Changsha 161
Jiaxing 158
Shanghai 146
Tianjin 135
Los Angeles 122
Redwood City 112
Orange 102
Jinan 92
New York 87
Norwalk 81
Mountain View 79
Ningbo 78
Sassari 78
Auburn Hills 74
Washington 72
Rome 64
Saint Petersburg 63
Pune 62
London 59
Zhengzhou 54
Hefei 46
Kunming 41
Brussels 40
Taizhou 40
Dong Ket 32
Falls Church 31
Borås 29
Redmond 29
Millbury 25
Hangzhou 22
Seoul 20
Wuhan 20
Chicago 19
Columbus 19
Molise 17
Palermo 17
Pescara 17
Torino 15
San Mateo 14
Tappahannock 14
Treviso 14
Atlanta 13
Augusta 13
Kilburn 13
Mumbai 13
Fuzhou 12
Indiana 12
Padova 12
Settimo Torinese 12
Walnut 12
Bologna 11
Catania 11
Frankfurt am Main 11
Phoenix 11
Rockville 11
Quartu Sant'elena 10
Berlin 9
Chengdu 9
Chiswick 9
Dublin 9
Edinburgh 9
Paris 9
Alghero 8
Andover 8
Hounslow 8
Manchester 8
Messina 8
Prescot 8
Simi Valley 8
Brescia 7
Buffalo 7
Monmouth Junction 7
Totale 348.624
Nome #
Long-acting reversible contraception (LARC) with the intrauterine system with levonorgestrel (6 mcg/d): observational study on the acceptability, quality of life, and sexuality in Italian women 3.833
Pre-labor rupture of membranes (PROM) and modern metabolomics 3.762
PROM and labour effects on urinary metabolome: a pilot study 3.463
Overview of elagolix for the treatment of endometriosis 3.360
Urinary metabolomics of pregnant women at term: a combined GC/MS and NMR approach 3.257
Effect of Estradiol valerate plus dienogest on body composition of healthy women in the menopausal transition: a prospective one-year evaluation 3.250
Three-dimensional ultrasonography in the diagnosis of deep endometriosis 3.124
Review and meta-analysis of prospective randomized controlled trials (RCTs) comparing laparo-endoscopic single site and multiport laparoscopy in gynecologic operative procedures 3.041
Systemic therapy for the treatment of endometrial cancer 2.925
Vaginosi batterica: efficacia di un trattamento locale con un gel vaginale a base di una frazione batterica derivata da Propionibacterium acnes 2.891
Clinical effect of hormonal replacement therapy with estradiol associated with noretisterone or drospirenone. A prospective randomized placebo controlled study 2.850
Olfactory performance in relation to sex and hormonal profile in humans 2.787
The stimulation of the vaginal immune system with short-term administration of a vaginal gel containing fraction of Propionibacterium acnes, hyaluronic acid and polycarbophil is efficacious in vaginal infections dependent on disorders in the vaginal ecosystem 2.785
Repeated two cycles of ulipristal acetate treatment improve the quality of life in premenopausal women with heavy menstrual bleeding dependent on uterine myomas, without impairment of bone health 2.749
Accuracy of transvaginal ultrasound for diagnosis of deep endometriosis in uterosacral ligaments, rectovaginal septum, vagina and bladder: systematic review and meta-analysis. 2.704
Body composition and psychological improvement in healthy premenopausal women assuming the oral contraceptive containing micronized estradiol (E2) and nomegestrol acetate (NOMAC) 2.594
Accuracy of transvaginal ultrasound for diagnosis of deep endometriosis in the rectosigmoid: systematic review and meta-analysis 2.574
Safe endobag morcellation in a single-port laparoscopy subtotal hysterectomy 2.550
Research development of a new GnRH antagonist (Elagolix) for the treatment of endometriosis: a review of the literature 2.550
Endometrial ablation: first- vs. second-generation techniques 2.461
Studio epidemiologico sull’osteoporosi postmenopausale 2.436
Renal tumors in pregnancy: a systematic review 2.416
Vilaprisan for treating uterine fibroids 2.410
Association between different morphological types and abnormal karyotypes in early pregnancy loss 2.392
Dismenorrea e endometriosi: una innovativa alternativa alla terapia farmacologica nel controllo del dolore 2.367
Reduced serum level of THDOC, an anticonvulsant steroid, in women with perimenstrual catamenial epilepsy 2.334
Sexual function in women with deep endometriosis: correlation with quality of life, intensity of pain, depression, anxiety, and body image 2.277
Changes of olfactory sensitivity related to sex and hormonal profile in humans 2.240
Clinical utility of elagolix as an oral treatment for women with uterine fibroids: A short report on the emerging efficacy data 2.211
Dienogest. A possible conservative approach in bladder endometriosis. Results of a pilot study 2.189
Very low dose of flutamide in the treatment of hyperandrogenism 2.160
Studio osservazionale sul contraccettivo ormonale contenente estradiolo valerato e dienogest in formulazione quadrifasica: accettabilità, effetto favorevole sulla composizione corporea e sullo stato psicologico. 2.129
“CG Fem, PI 82, Vitamina E” per la terapia della menopausa: quali vantaggi per la sintomatologia neurovegetativa peri-post menopausale 2.100
Focusing on surgery results in infertile patients with deep endometriosis 2.069
Placental growth factor and preterm delivery 2.055
Rupture of renal angiomyolipoma in pregnancy 2.035
Pharmacokinetic evaluation of ulipristal acetate for uterine leiomyoma treatment 1.960
Studio osservazionale sul contraccettivo ormonale a base di E2 1,5 mg/NOMAC 2,5 mg in formulazione monofasica 1.940
Resistenza all’insulina nella PCOS e trattamento con inositolo e acido alfa-lipoico 1.934
Deep Infiltrating Endometriosis: Comparison Between 2-Dimensional Ultrasonography (US), 3-Dimensional US, and Magnetic Resonance Imaging 1.923
Pregnancy Complications After Hysteroscopic Metroplasty: A Ten-Year Case-Control Study 1.900
Obesity-related lipid profile and altered insulin incretion in adolescents with polycystic ovary syndrome 1.897
STUDIO OSSERVAZIONALE SUL CONTRACCETTIVO ORMONALE A BASE DI ESTRADIOLO (E2) 1.5 MG/NOMEGESTROLO (NOMAC) 2.5 MG IN FORMULAZIONE MONOFASICA: ACCETTABILITA', EFFETTO FAVOREVOLE SULLA COMPOSIZIONE CORPOREA E SUI PARAMETRI ANTROPOMETRICI 1.813
Does the clinical information play a role in the magnetic resonance diagnostic confidence analysis of ovarian and deep endometriosis? 1.806
Screening e diagnosi del Diabete Gestazionale in Sardegna: risultati a confronto. 1.800
Modificazioni dell’umore e del comportamento nel puerperio: quali fattori di rischio? 1.786
SARCOPENIA: DIAGNOSI E PROSPETTIVE TERAPEUTICHE 1.783
Il bi-test: solo screening di cromosomopatie fetali? 1.782
Correlazione fra anomalie morfologiche ecografiche e cariotipo patologico negli aborti precoci 1.772
Past, present and future ultrasonographic techniques for analyzing ovarian masses 1.757
The quantitative insulin sensitivity check index is not able to detect early metabolic alterations in young patients with polycystic ovarian syndrome 1.676
Autoimmunity in gestational diabetes mellitus in Sardinia: a preliminary case-control report 1.661
Progestins for symptomatic endometriosis: Results of clinical studies 1.661
Comparison of laparoscopic intraoperative sentinel lymph node detection rates obtainable with vital dye or radioactive colloid in early stage endometrial cancer. A preliminary prospective trial 1.656
Psychological effect of the oral contraceptive formulation containing 3 mg of drospirenone plus 30 mu g of ethinyl estradiol 1.643
Fattore di Crescita Placentare (PlGF): correlazioni con la funzione placentare 1.625
Modificazione dell'umore in gravidanza e nel post-partum: ruolo degli integratori 1.624
ADDITIONAL VALUE OF CA-125 TO ULTRASOUND FOR PREDICTING SPECIFIC DIAGNOSIS OF BENIGN ADNEXAL CYSTS IN PREMENOPAUSAL 1.583
Diagnosi isteroscopica del tumore endometriale: nostra esperienza 1.577
Diagnostic confidence analysis in the magnetic resonance imaging of ovarian and deep endometriosis: comparison with surgical results 1.575
Tissue characterization using mean gray value analysis in deep infiltrating endometriosis 1.566
CARATTERISTICHE DELLA "MESTRUAZIONE", DELLA PRESSIONE ARTERIOSA E DEI SINTOMI PSICOLOGICI IN CORSO DI SEI CICLI DI TRATTAMENTO CON IL CONTRACCETTIVO ORMONALE A BASE DI E2 1.5 MG/NOMAC 2.5 MG 1.514
Confronto tra diagnosi isteroscopica e istologica delle patologie endometriali maligne, nostra esperienza 1.494
Observational study on the stability of the psychological status during normal pregnancy and increased blood levels of neuroactive steroids with GABA-A receptor agonist activity. 1.451
Ultrasound features of rare primary malignant ovarian tumors 1.438
Diagnostic performance of transvaginal power Doppler ultrasound for predicting malignancy of adnexsal masses in in symptomatic and asymptomatic women 1.436
STUDIO OSSERVAZIONALE SUL CONTRACCETTIVO ORMONALE CONTENENTE ESTRADIOLO VALERATO E DIENOGEST IN FORMULAZIONE QUADRIFASICA: ACCETTABILITA', EFFETTO FAVOREVOLE SULLA COMPOSIZIONE CORPOREA E SULLO STATO PSICOLOGICO 1.435
Endometriosis: the role of magnetic resonance imaging 1.434
OC24: The role of magnetic resonance imaging and transvaginal ultrasonography in patients with an adnexal mass and chronic pelvic pain or infertility 1.405
Dilated lateral ventricles and micrognathia by ultrasound exsamination in fetus with mosaic trisomy 9 1.378
Glucose metabolism and insulin resistance in women with polycystic ovary syndrome during therapy with oral contraceptives containing cyproterone acetate or desogestrel 1.374
LE ALTERAZIONI DELLA FASE OVULATORIA 1.372
La genetica dell'endometriosi 1.365
Rationale and design of ASTEROID 2, a randomized, placebo- and active comparator-controlled study to assess the efficacy and safety of vilaprisan in patients with uterine fibroids 1.352
Low androgenization index in elderly women and elderly men with Alzheimer's disease 1.287
Placental growth factor and placental perfusion 1.283
Dietary composition of pregnant women in south sardinia 1.277
Efficacy of intravenous tramadol treatment for reducing pain during office diagnostic hysteroscopy 1.276
INDICAZIONE AL PARTO CESAREO PRESSO LA CLINICA OSTETRICA E GINECOLOGICA DI CAGLIARI: SU QUALI POSSIAMO RIDURRE IL RICORSO AL PARTO CESAREO? 1.244
The oral contraceptive containing 30 microg of ethinylestradiol plus 3 mg of drospirenone is able to antagonize the increase of extracellular water occurring in healthy young women during the luteal phase of the menstrual cycle: an observational study 1.231
Alexithymia in women with deep endometriosis? A pilot study 1.227
Ultrasound features of metastases in the ovary depending of the origin of the primary tumor 1.207
Evidence that in healthy young women, a six-cycle treatment with oral contraceptive containing 30 mcg of ethinylestradiol plus 2 mg of chlormadinone acetate reduces fat mass 1.207
Pattern of bone markers during pregnancy and their changes after delivery. 1.203
Short-term variations in bone remodeling markers of an oral contraception formulation containing 3 mg of drospirenone plus 30 mu g of ethinyl estradiol: observational study in young postadolescent women 1.202
Placental massive perivillous fibrin deposition after a previous uncomplicated term pregnancy: report of two cases. 1.164
ANALGESIA EPIDURALE E INCIDENZA DI TAGLIO CESAREO. 1.155
EZIOPATOGENESI DEI MIOMI UTERINI 1.155
Potentially beneficial cardiovascular effects of melatonin administration in women 1.155
Criteri diagnostici di PCOS: recenti evoluzioni 1.147
Effect of desogestrel-containing oral contraceptived on vascular reactivity and catecholamine levels 1.140
B-mode and Power Doppler Ultrasound in Adnexsal Masses 1.125
Diagnosis of metabolic disorders in women with polycystic ovary syndrome 1.119
Observational study on the efficacy of tibolone in counteracting early carotid atherosclerotic lesions in postmenopausal women 1.106
Intraoperative sentinel lymph node detection by vital dye through laparoscopy or laparotomy in early endometrial cancer 1.103
Obesity realated lipid profile and altered insulin incretion in adolescent with PCOS 1.102
The treatment of polycystic ovary syndrome 1.094
null 1.083
Correlazioni tra composizione corporea ed età 1.071
Effects of melatonin on vascular reactivity, cathecolamine levels, and blood pressure in healthy men 1.049
Totale 187.890
Categoria #
all - tutte 515.012
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 515.012


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202060.693 0 0 0 1.566 24.312 15.143 9.998 2.632 1.610 1.216 1.932 2.284
2020/202183.774 3.384 2.778 3.589 20.749 18.396 10.152 9.566 4.890 1.453 3.435 3.317 2.065
2021/202221.003 2.026 1.912 976 1.605 2.219 1.676 1.714 1.144 1.730 1.563 2.131 2.307
2022/202332.914 3.274 3.477 3.426 2.326 2.319 2.863 1.216 6.240 2.374 1.667 2.477 1.255
2023/202441.278 2.652 2.451 2.455 3.441 4.144 6.068 5.935 2.207 2.275 3.189 3.483 2.978
2024/202526.296 5.661 9.439 8.792 2.404 0 0 0 0 0 0 0 0
Totale 366.809